Iron, cholesterol, and the risk of cancer in an 18-year cohort

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 4, 2005, Pages 505-509

  Wells, Brian J ^a   Mainous III, Arch G ^b   Everett, Charles J ^b   Gill, James M ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Cholesterol; Cohort; Iron; Oxidative stress

Indexed keywords

CHOLESTEROL; IRON;

ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM; NUTRITION; RISK FACTOR; TIME; UNITED STATES;

ADULT; AGED; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; IRON; MALE; MIDDLE AGED; NEOPLASMS; NUTRITION SURVEYS; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 33646672681     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ahmad K (2002). Hepatitis B risk factors for liver cancer. Lancet Infect Dis, 2, 511.
2. Fischer JG, Glauert HP, Yin T, et al (2002). Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF-kappaB activation induced by the peroxisome proliferator, Wy-14,643. J Nutr, 132, 2525-31.
3. Galli F, Piroddi M, Annetti C, et al (2005). Oxidative stress and reactive oxygen species. Contrib Nephrol, 149, 240-60.
4. Glei M, Latunde-Dada GO, Klinder A, et al (2002). Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat Res, 519, 151-61.
5. Halliwell B (2002)..Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic Biol Med, 32, 968-74.
6. Halliwell B, Gutteridge J (1990). Oxygen radicals in biological systems. Part B: Oxygen radicals and antioxidants. Methods Enzymol, 186, 1-766.
7. Hristozov D, Gadjeva V, Vlaykova T, et al (2001). Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem, 109, 331-6.
8. Johnson S (2001). The possible crucial role of iron accumulation combined with low tryptophan, zinc and manganese in carcinogenesis. Med Hypotheses, 57, 539-43.
9. Knekt P, Reunanen A, Takkunen H, et al (1994). Body iron stores and risk of cancer. Int J Cancer, 56, 379-82.
10. Kuriki K, Hamajima N, Chiba H, et al (2005). Relation of the CD36 gene A52C polymorphism to the risk of colorectal cancer among Japanese, with reference to with the aldehyde dehydrogenase 2 gene Glu487Lys polymorphism and drinking habit. Asian Pac J Cancer Prev, 6, 62-8.
11. Mainous AG, 3rd, Wells BJ, Koopman RJ, et al (2005). Iron, lipids, and risk of cancer in the Framingham Offspring cohort. Am J Epidemiol, 161, 1115-22.
12. Mates JM, Sanchez-Jimenez FM (2000). Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol, 32, 157-70.
13. Platt N, Gordon S (2001). Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J Clin Invest, 108, 649-54.
14. Poulsen HE, Prieme H, Loft S (1998). Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev, 7, 9-16.
15. Poynter JN, Gruber SB, Higgins PD, et al (2005). Statins and the risk of colorectal cancer. N Engl J Med, 352, 2184-92.
16. Schatzkin A, Hoover RN, Taylor PR, et al (1987). Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Lancet, 2, 298-301.
17. Schoenfeld D (1982). Residuals for the proportional hazards model. Biometrika, 69, 239-41.
18. Shannon J, Tewoderos S, Garzotto M, et al (2005). Statins and Prostate Cancer Risk: A Case-Control Study. Am J Epidemiol, 162, 318-325.
19. Sharan R, Schoen RE (2002). Cancer in inflammatory bowel disease. An evidence-based analysis and guide for physicians and patients. Gastroenterol Clin North Am, 31, 237-54.
20. Stevens RG, Graubard BI, Micozzi MS, et al (1994). Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer, 56, 364-9.
21. Stevens RG, Jones DY, Micozzi MS, et al (1988). Body iron stores and the risk of cancer. N Engl J Med, 319, 1047-52.
22. Suzuki K, Ito Y, Ochiai J, et al (2003). Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev, 4, 259-66.
23. Weinberg ED (1996). The role of iron in cancer. Eur J Cancer Prev, 5, 19-36.
24. Witte DL, Crosby WH, Edwards CQ, et al (1996). Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta, 245, 139-200.
25. Wu T, Sempos CT, Freudenheim JL, et al (2004). Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol, 14, 195-201.
26. Xu J, Zheng SL, Komiya A, et al (2002). Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet, 32, 321-5.